BriaCell Therapeutics Analyst Ratings
BriaCell Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest BriaCell Therapeutics (BCTX) rating was a maintained with a price target of $25.00 to $20.00. The current price BriaCell Therapeutics (BCTX) is trading at is $5.84, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/03/2023 | 242.47% | HC Wainwright & Co. | $25 → $20 | Maintains | Buy |
| 06/28/2023 | 328.08% | HC Wainwright & Co. | → $25 | Reiterates | Buy → Buy |
| 02/24/2023 | 328.08% | HC Wainwright & Co. | → $25 | Reiterates | → Buy |
| 02/14/2022 | 328.08% | HC Wainwright & Co. | → $25 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 10/03/2023 | 242.47% | HC Wainwright公司 | $25→$20 | 维护 | 买 |
| 2023年6月28日 | 328.08% | HC Wainwright公司 | →$25 | 重申 | 购买→购买 |
| 02/24/2023 | 328.08% | HC Wainwright公司 | →$25 | 重申 | →购买 |
| 02/14/2022 | 328.08% | HC Wainwright公司 | →$25 | 开始承保 | →购买 |
What is the target price for BriaCell Therapeutics (BCTX)?
Briacell治疗公司(BCTX)的目标价格是多少？
The latest price target for BriaCell Therapeutics (NASDAQ: BCTX) was reported by HC Wainwright & Co. on October 3, 2023. The analyst firm set a price target for $20.00 expecting BCTX to rise to within 12 months (a possible 242.47% upside). 3 analyst firms have reported ratings in the last year.
Briacell治疗公司(纳斯达克代码：BCTX)的最新目标价是由HC Wainwright&Co.于2023年10月3日报道的。这家分析公司将目标价定为20美元，预计BCTX将在12个月内上涨至(可能上涨242.47%)。3家分析公司在过去一年公布了评级。
What is the most recent analyst rating for BriaCell Therapeutics (BCTX)?
Briacell治疗公司(BCTX)的最新分析师评级是什么？
The latest analyst rating for BriaCell Therapeutics (NASDAQ: BCTX) was provided by HC Wainwright & Co., and BriaCell Therapeutics maintained their buy rating.
Briacell治疗公司(纳斯达克代码：BCTX)的最新分析师评级由HC Wainwright&Co.提供，Briacell治疗公司维持买入评级。
When is the next analyst rating going to be posted or updated for BriaCell Therapeutics (BCTX)?
Briacell治疗公司(BCTX)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BriaCell Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BriaCell Therapeutics was filed on October 3, 2023 so you should expect the next rating to be made available sometime around October 3, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与BriaCell Treeutics的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Briacell治疗公司的上一次评级是在2023年10月3日提交的，所以你应该预计下一次评级将在2024年10月3日左右的某个时候提供。
Is the Analyst Rating BriaCell Therapeutics (BCTX) correct?
分析师对Briacell Treeutics(BCTX)的评级正确吗？
While ratings are subjective and will change, the latest BriaCell Therapeutics (BCTX) rating was a maintained with a price target of $25.00 to $20.00. The current price BriaCell Therapeutics (BCTX) is trading at is $5.84, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Briacell治疗公司(BCTX)评级保持不变，目标价在25.00美元至20.00美元之间。BriaCell Treateutics(BCTX)目前的交易价格为5.84美元，超出了分析师的预测范围。